We help
biotech, medtech, and cosmetic R&D teams
make the right research, funding, and partnership decisions — before execution becomes expensive
Clarity before capital. Confidence before Execution.
Integrated funding strategy, preclinical navigation, and commercial positioning for early-stage and scaling life science programmes.
Response within 24-48 hrs • NDA available upon request
Most early-stage biotech, medtech, and cosmetic R&D do not fail because of weak science.
They fail when decision-critical research, funding, and partnership decisions are made too early.
In practice, this leads to:
✅ Studies that do not answer decision-critical questions.
✅ Funding pursued without clear scientific and market positioning
✅ CROs selected before scientific and strategic alignment
✅ Momentum lost as regulatory and investor scrutiny increases
THESE ARE NOT EXECUTION PROBLEMS.
They are decision problems
Why PROMAFUN CRIO?
PROMAFUN CRIO operates before execution – where outcomes are determined.
We work with early-stage and scale-ups in biotech, medtech, and cosmetic R&D teams at critical transition points: before funding rounds, CRO selection and market entry.
We act as a Contract Research Intermediary (CRI) and strategic funding partner — the layer where scientific, financial, and operational decisions are shaped before they become costly.
We integrate development strategy, funding architecture, outsourcing design, and partnership positioning into a coherent decision framework.
Not a CRO
We do not operate laboratories, we design decision-critical studies and guide you in selecting and managing the right CRO partners for execution.
Not a Grant factory
We do not mass-produce applications, we align your funding strategy with your scientific and commercial positioning.
Not a Generic Consultancy
We do not stop at advice, we stay engaged until your key scientific, financial, and operational decisions are validated.
Our Services — Strategic Support for Research & Health Innovation
From proposal development to project implementation.
Clear guidance. Scientific rigor. Real-world impact.
Backed by EU & Dutch funding programmes:
Funding Strategy & Grant Support
Strategic grant writing and co-writing embedded in your R&D strategy and development planning — from call selection to submission, aligned with development milestones and positioning.
Our support includes:
• Non-dilutive funding strategy, programme mapping & call selection
Translating funding landscapes into realistic development pathways.
• Grant writing & Proposal development
Strategic drafting and co-writing aligned with evaluation criteria, development milestones, and regulatory pathways.
• Proposal review, Positioning & Evaluation alignment
Critical review and optimisation of proposal structure, impact narrative, and scoring logic.
• Dissemination planning & Science communication alignment
Integration of dissemination, impact, and stakeholder engagement strategies into funding proposals.
• Grant management & Coordination
Post-award coordination, reporting support, and compliance alignment across partners and funders.
Business Development & Strategic Partnerships
Strategic positioning and partnership development aligned with scientific maturity, funding trajectories, and downstream commercial objectives.
Our support includes:
• Value Proposition Development & Positioning
Translation of scientific assets into credible value narratives for partners, investors, and collaborators.
• Partner targeting, Investor Readiness & Commercial Support
Identification, preparation, and engagement of strategic partners and investors based on technical and commercial fit.
• Investor and partner materials
Development of technically sound pitch decks, data packages, and due diligence documentation.
• Collaboration structuring & Consortium development
Design of research and commercial collaborations, governance models, and role allocation.
• Technical due diligence preparation
Preparation of scientific, regulatory, and development documentation for partner and investor review.
• Market and application pathway analysis
Assessment of target indiciations, adoption pathways, reimbursement context, and competitive positioning.
Our Contract Research Intermediary (CRI) Services
Preclinical Strategy & CRO Navigation embedded in your development trajectory — ensuring outsourced studies answer decision-critical questions.
Our support includes:
• Study Design & Feasibility assessment
Translation of development objectives into technically and scientifically defensible study designs.
• Operational Coordination & Study Management
Coordination of outsourced studies, timelines, communication workflows, and deliverable tracking.
• Compliance, Quality & Site Auditing
Alignment of CRO operations with regulatory, ethical, and quality requirements.
• Pharmacology & Toxicology strategy and studies
Integration of safety, PK/PD, and toxicology programmes into development and regulatory planning.
• Data Management & Biostatistics
Structured data handling, statistical planning, and analysis aligned with regulatory and funding requirements.
• Efficacy studies for cancer, bacterial & virus infections
〉Efficacy studies for cancer and virus infections vaccines drug compounds and antibodies
Working With PROMAFUN CRIO
Our work supports teams operating in:
• EU and national funding programmes
• Translational and preclinical development
• Public-private research consortia
• Venture-backed innovation programmes
We engage when decisions have long-term consequences.
Discuss Your Project Context
If you are preparing critical development, funding, or partnerships decisions, we invite you to discuss your project context with our team.
Instant Support
READY TO ACCELERATE YOUR RESEARCH AND BUSINESS? LET’S EXPLORE HOW WE CAN SUPPORT YOUR NEXT STEP.
FILL THE FORM AND OUR TEAM WILL GET BACK AT YOU.
Contact Us
Contact Us For Additional Info
Not ready for a full engagement yet?
Start with an Entry-Level Strategic Assessment
.
A focused, expert-led review to determine your current readiness for funding and strategic positioning.
Starting here is a low-risk entry point before committing to larger projects.
Many early-stage teams invest time and money before key assumptions are fully tested.
Our entry-level assessments help you identify gaps, risks, and priorities, so your next step is informed, not speculative.
PROMAFUN CRIO Blog:
Navigating the Future of Clinical Research – Insights, Trends, and Strategies for Success
